NO940400D0 - Farmasoeytisk preparat inneholdene karbakol og andre kolinergiske stoffer - Google Patents
Farmasoeytisk preparat inneholdene karbakol og andre kolinergiske stofferInfo
- Publication number
- NO940400D0 NO940400D0 NO940400A NO940400A NO940400D0 NO 940400 D0 NO940400 D0 NO 940400D0 NO 940400 A NO940400 A NO 940400A NO 940400 A NO940400 A NO 940400A NO 940400 D0 NO940400 D0 NO 940400D0
- Authority
- NO
- Norway
- Prior art keywords
- carbacol
- pharmaceutical preparation
- preparation containing
- cholinergic
- cholinergic substances
- Prior art date
Links
- AIXAANGOTKPUOY-UHFFFAOYSA-N carbachol Chemical compound [Cl-].C[N+](C)(C)CCOC(N)=O AIXAANGOTKPUOY-UHFFFAOYSA-N 0.000 title abstract 2
- 230000001713 cholinergic effect Effects 0.000 title abstract 2
- 239000000126 substance Substances 0.000 title abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- HJJPJSXJAXAIPN-UHFFFAOYSA-N arecoline Chemical compound COC(=O)C1=CCCN(C)C1 HJJPJSXJAXAIPN-UHFFFAOYSA-N 0.000 abstract 2
- 208000003556 Dry Eye Syndromes Diseases 0.000 abstract 1
- 206010013774 Dry eye Diseases 0.000 abstract 1
- 208000009319 Keratoconjunctivitis Sicca Diseases 0.000 abstract 1
- 229960000910 bethanechol Drugs 0.000 abstract 1
- NZUPCNDJBJXXRF-UHFFFAOYSA-O bethanechol Chemical compound C[N+](C)(C)CC(C)OC(N)=O NZUPCNDJBJXXRF-UHFFFAOYSA-O 0.000 abstract 1
- 229960004484 carbachol Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- HEDXEAAVEOJUCR-UHFFFAOYSA-N furtrethonium Chemical compound C[N+](C)(C)CC1=CC=CO1 HEDXEAAVEOJUCR-UHFFFAOYSA-N 0.000 abstract 1
- 229950008234 furtrethonium Drugs 0.000 abstract 1
- NZWOPGCLSHLLPA-UHFFFAOYSA-N methacholine Chemical compound C[N+](C)(C)CC(C)OC(C)=O NZWOPGCLSHLLPA-UHFFFAOYSA-N 0.000 abstract 1
- 229960002329 methacholine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9102340A SE9102340D0 (sv) | 1991-08-13 | 1991-08-13 | Pharmaceutical composition containing carbachol and othercholinergic substances |
| PCT/SE1992/000542 WO1993003718A1 (en) | 1991-08-13 | 1992-08-07 | Pharmaceutical composition containing carbachol and other cholinergic substances |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO940400L NO940400L (no) | 1994-02-07 |
| NO940400D0 true NO940400D0 (no) | 1994-02-07 |
| NO306447B1 NO306447B1 (no) | 1999-11-08 |
Family
ID=20383456
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO940400A NO306447B1 (no) | 1991-08-13 | 1994-02-07 | Anvendelse av kolinerg substans for behandling av törre öyne |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US5679713A (no) |
| EP (2) | EP0528776A1 (no) |
| JP (1) | JPH06509801A (no) |
| AT (1) | ATE172114T1 (no) |
| AU (1) | AU671805B2 (no) |
| CA (1) | CA2114239C (no) |
| DE (1) | DE69227324T2 (no) |
| DK (1) | DK0661968T3 (no) |
| ES (1) | ES2123005T3 (no) |
| FI (1) | FI108516B (no) |
| HU (1) | HU221592B (no) |
| NO (1) | NO306447B1 (no) |
| SE (1) | SE9102340D0 (no) |
| WO (1) | WO1993003718A1 (no) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0969813T3 (da) * | 1997-02-24 | 2005-01-31 | Sla Pharma Ag | Topisk farmaceutisk sammensætning omfattende et kolinergt middel eller et calciumkanalblokerende middel |
| WO1999007354A2 (en) * | 1997-08-08 | 1999-02-18 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
| US6711436B1 (en) | 1997-08-08 | 2004-03-23 | Duke University | Compositions, apparatus and methods for facilitating surgical procedures |
| US6395758B1 (en) * | 1998-08-14 | 2002-05-28 | Gpi Nil Holdings, Inc. | Small molecule carbamates or ureas for vision and memory disorders |
| US7220422B2 (en) * | 2003-05-20 | 2007-05-22 | Allergan, Inc. | Methods and compositions for treating eye disorders |
| US8299079B2 (en) | 2009-05-22 | 2012-10-30 | Kaufman Herbert E | Preparations and methods for ameliorating or reducing presbyopia |
| BR112012011086A2 (pt) | 2009-11-12 | 2016-07-05 | Acacia Pharma Ltd | uso de betanecol para o tratamento de xerostomia |
| WO2016159351A1 (ja) * | 2015-04-03 | 2016-10-06 | 参天製薬株式会社 | 涙腺ドラッグデリバリーシステム |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2185220A (en) * | 1938-08-17 | 1940-01-02 | Smith Kline French Lab | Medicinal agent |
| GB1386864A (en) * | 1972-02-11 | 1975-03-12 | Avicon Inc | Micro-crystalline collage-containing pharmaceutical compositions useful for topical applications |
| JPH02500360A (ja) * | 1986-07-28 | 1990-02-08 | リポソーム テクノロジー，インコーポレイテッド | 粘膜組織上での高い保持力を有するリポソーム |
| US4804539A (en) * | 1986-07-28 | 1989-02-14 | Liposome Technology, Inc. | Ophthalmic liposomes |
-
1991
- 1991-08-13 SE SE9102340A patent/SE9102340D0/xx unknown
-
1992
- 1992-08-07 AU AU24631/92A patent/AU671805B2/en not_active Ceased
- 1992-08-07 WO PCT/SE1992/000542 patent/WO1993003718A1/en not_active Ceased
- 1992-08-07 EP EP92850187A patent/EP0528776A1/en active Pending
- 1992-08-07 JP JP5504252A patent/JPH06509801A/ja not_active Ceased
- 1992-08-07 HU HU9400405A patent/HU221592B/hu not_active IP Right Cessation
- 1992-08-07 ES ES92918041T patent/ES2123005T3/es not_active Expired - Lifetime
- 1992-08-07 CA CA002114239A patent/CA2114239C/en not_active Expired - Fee Related
- 1992-08-07 DK DK92918041T patent/DK0661968T3/da active
- 1992-08-07 DE DE69227324T patent/DE69227324T2/de not_active Expired - Fee Related
- 1992-08-07 EP EP92918041A patent/EP0661968B1/en not_active Expired - Lifetime
- 1992-08-07 AT AT92918041T patent/ATE172114T1/de not_active IP Right Cessation
-
1994
- 1994-02-07 NO NO940400A patent/NO306447B1/no unknown
- 1994-02-11 FI FI940637A patent/FI108516B/fi not_active IP Right Cessation
- 1994-10-20 US US08/326,797 patent/US5679713A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ES2123005T3 (es) | 1999-01-01 |
| CA2114239C (en) | 2003-10-21 |
| JPH06509801A (ja) | 1994-11-02 |
| EP0661968B1 (en) | 1998-10-14 |
| FI940637L (fi) | 1994-02-11 |
| NO940400L (no) | 1994-02-07 |
| FI940637A0 (fi) | 1994-02-11 |
| HU221592B (hu) | 2002-11-28 |
| WO1993003718A1 (en) | 1993-03-04 |
| AU2463192A (en) | 1993-03-16 |
| DE69227324D1 (de) | 1998-11-19 |
| ATE172114T1 (de) | 1998-10-15 |
| AU671805B2 (en) | 1996-09-12 |
| NO306447B1 (no) | 1999-11-08 |
| US5679713A (en) | 1997-10-21 |
| EP0528776A1 (en) | 1993-02-24 |
| CA2114239A1 (en) | 1993-02-14 |
| DE69227324T2 (de) | 1999-04-29 |
| EP0661968A1 (en) | 1995-07-12 |
| SE9102340D0 (sv) | 1991-08-13 |
| HUT65946A (en) | 1994-08-29 |
| DK0661968T3 (da) | 1999-06-23 |
| HU9400405D0 (en) | 1994-05-30 |
| FI108516B (fi) | 2002-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITRM920155A0 (it) | Composizione farmaceutica contenente 3-2 (dimetilammino) etil-n-metil-1h-indol-5-metansolfonammide, e relativo procedimento di preparazione e trattamento con essa di mammiferi. | |
| DK0608322T3 (da) | Forbedret hudpenetreringssystem til forbedret topisk frembringelse af lægemidler | |
| TW264480B (no) | ||
| IL126038A0 (en) | Novel benzothiepines and derivatives thereof and pharmaceutical compositions comprising them | |
| BG101118A (en) | Therapeutical compounds | |
| ATE207342T1 (de) | Gegen hautalterung wirksame stoffe oder wirkstoffkombinationen und zubereitungen | |
| ATE140388T1 (de) | Zusammensetzungen enthaltend omega conotoxin peptide derivate und deren verwendung zur behandlung von ischämie-artigen neuronalen schädigungen | |
| NO982310L (no) | Protegriner | |
| KR930012022A (ko) | 뇌조직 보호용 모다피닐(Modafinil) | |
| AU2905092A (en) | Pharmaceutical dipeptide compositions and methods of use thereof | |
| NO940266L (no) | Indre strålingsskade | |
| DE69531098D1 (de) | Piperidine und pyrrolidine | |
| DE69826023D1 (de) | Verwendung von substanzen mit oxytocinwirkung zur herstellung eines arzneimittels zur behandlung affektiver schmerzsyndrome | |
| RU95111308A (ru) | Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция | |
| BR9500436A (pt) | Produtos uso de um g-csf uso de uma proteína tnf ligante processo para o tratamento e/ou prevenção do choque séptico | |
| NO940400D0 (no) | Farmasoeytisk preparat inneholdene karbakol og andre kolinergiske stoffer | |
| DE69927584D1 (de) | Pharmazeutische zubereitungen zur behandlung von magengeschwüren | |
| NO990440L (no) | Preparat som innbefatter mupirocin og klorheksidin | |
| WO2000072833A3 (de) | Pharmazeutische zubereitungen zur hemmung von spimgomyelinase | |
| NO934832D0 (no) | Farmasoeytisk sammensetning for forhindring eller behandling av ar terioscherose | |
| BR9813098A (pt) | Uso de glicosaminoglicans, preparação farmacêutica, e, combinaçào | |
| NO922635D0 (no) | Ny anvendelse av benzimidazolin-2-okso-1-karboksylsyrederivater | |
| RU92004541A (ru) | Лекарственные средства для лечения воспалительных состояний или для аналгезии | |
| BG95724A (en) | Medicaments with analgetic, antiphlogestic and antibacterial effect for external use | |
| RU93053043A (ru) | Новые производные тиомаринола, способ их получения, фармацевтическая композиция и способ лечения |